Found: 8
Select item for more details and to access through your institution.
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Oncology dose optimization paradigms: knowledge gained and extrapolated from approved oncology therapeutics.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Optimized scaling of translational factors in oncology: from xenografts to RECIST.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A bavachinin analog, D36, induces cell death by targeting both autophagy and apoptosis pathway in acute myeloid leukemia cells.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia.
- Published in:
- 2022
- By:
- Publication type:
- journal article